Evidence map›Paper›PMID 32796843›Full record

ArticleNature communications2020

Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr

Huan Tao, Jiansheng Huang, Patricia G Yancey, Valery Yermalitsky, John L Blakemore, Youmin Zhang, Lei Ding, Irene Zagol-Ikapitte, Fei Ye, Venkataraman Amarnath and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 61 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Immune Mechanisms in Hypertension.Hypertension (Dallas, Tex. : 1979) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Repetitive sulfur dioxide exposure in mice models post-deployment respiratory syndrome.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Huan Tao *Department of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Jiansheng Huang *Department of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.ORCID http://orcid.org/0000-0002-5600-1737
Patricia G YanceyDepartment of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.ORCID http://orcid.org/0000-0002-1385-3366
Valery YermalitskyDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
John L BlakemoreDepartment of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Youmin ZhangDepartment of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Lei DingDepartment of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Irene Zagol-IkapitteDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Fei YeDepartment of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Venkataraman AmarnathDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Olivier BoutaudDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
John A OatesDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
L Jackson RobertsDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Sean S DaviesDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
MacRae F LintonDepartment of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. macrae.linton@vanderbilt.edu.ORCID http://orcid.org/0000-0002-9277-0453
Vanderbilt University · US

Funding

Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LINTON, MACRAE F · 2014 to 2025
$24.7M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
NHLBI NIH HHS P01 HL116263NIDDK NIH HHS U24 DK059637NIDDK NIH HHS U2C DK059637
6 · The paper itself

Abstract

Lipid peroxidation generates reactive dicarbonyls including isolevuglandins (IsoLGs) and malondialdehyde (MDA) that covalently modify proteins. Humans with familial hypercholesterolemia (FH) have increased lipoprotein dicarbonyl adducts and dysfunctional HDL. We investigate the impact of the dicarbonyl scavenger, 2-hydroxybenzylamine (2-HOBA) on HDL function and atherosclerosis in Ldlr

Indexed as

AnimalsAortaApolipoproteins EAtherosclerosisBenzylaminesCholesterolFemaleHumansHyperlipoproteinemia Type IIInflammationLipid PeroxidationLipoproteins, HDLLipoproteins, IDLMaleMalondialdehydeMice2-(aminomethyl)phenolapolipoprotein E (239-252), mouseApolipoproteins EBenzylaminesCholesterolLipoproteins, HDLLipoproteins, IDLMalondialdehydePeptide FragmentsReceptors, LDL

Identifiers

PMID32796843
PMCPMC7429830
OpenAlexW3049524872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.